Inventor · disambiguated record
Enda Kenny
Also filed as: KENNY ENDA
7 granted patents·2 pending applications·41 citations·filing 2010–2025
76Inventor score
Top patents by PatentIndex Score
9 records- 0191US8642548B2Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndromeRICHARDSON PETER·Filed 2010·Granted Feb 4, 2014·41 cites·19 claims
- 0276US12390495B2Micronized eggshell membrane particles and the use thereof to promote the healing of woundsBIOVOTEC AS·Filed 2024·Granted Aug 19, 2025·0 cites·23 claims
- 0365US2024293515A1Stable liquid formulations of glucagon-like peptide 1 or analogues thereofROSE PHARMA INC·Filed 2024·Application pending·0 cites
- 0457US11980655B2Methods of treatment with stable liquid formulations of glucagon-like peptide 1 or analogues thereofROSE PHARMA INC·Filed 2021·Granted May 14, 2024·0 cites·18 claims
- 0556US11058748B2Stable liquid formulations of glucagon-like peptide 1 or analogues thereofROSE PHARMA LLC·Filed 2020·Granted Jul 13, 2021·0 cites·15 claims
- 0652US11992508B2Micronized eggshell membrane particles and the use thereof to promote the healing of woundsBIOVOTEC AS·Filed 2015·Granted May 28, 2024·0 cites·13 claims
- 0746US11045578B2Tissue engineering scaffolds comprising particulate egg shell membraneBIOVOTEC AS·Filed 2016·Granted Jun 29, 2021·0 cites·21 claims
- 0845US10932952B2Dry biocompatible disintegratable films for delivering particulate egg shell membrane to a woundBIOVOTEC AS·Filed 2016·Granted Mar 2, 2021·0 cites·23 claims
- 0942US2025352622A1Glp-1 formulations and their usesROSE PHARMA INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Enda Kenny files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →